MYRIAD GENETICS, INC. Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
MYRIAD GENETICS, INC. (MYGN) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $100.00 thousand as of 2023-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2025-02-28
- 2023-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $100.00K.
- 2022-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $2.70M.
- 2021-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $200.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2023-12-31 | $100.00K 10-K · filed 2025-02-28 |
| 2022-12-31 | $2.70M 10-K · filed 2024-02-28 |
| 2021-12-31 | $200.00K 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |